# Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital

> **NCT04540094** · PHASE3 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 300 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Human albumin
- **DRUG:** Balanced crystalloid solution

## Key facts

- **NCT ID:** NCT04540094
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-09-12
- **Final completion:** 2023-04-30
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04540094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04540094, "Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04540094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*